TrialScientific reports2025

Effect of PCSK9 inhibitors on the quality of life in patients with acute coronary syndromes - exploratory analysis of the EMSIACS trial.

Anran Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.